Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Trial ID or NCT#
NCT00383604
Status
NOT RECRUITING
Purpose
To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
Official Title
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Investigator(s)
Stanley G. Rockson, MD
Cardiologist
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Contact us to find out if this trial is right for you.
Contact
Anne Marie Vaillant-Newman
6504984460
View on ClinicalTrials.gov
